January 25, 2024
Study: UAB researchers establish optimal immunosuppression regimen for pig-to-human kidney transplants
Currently used Food and Drug Administration-approved transplant drugs — with the addition of an also already FDA-approved complement inhibitor — are the optimal immunosuppression regimen for pig-to-human kidney transplants, according to a landmark discovery by University of Alabama at Birmingham investigators. The peer-reviewed research is published today in the Journal of Clinical Investigation.
Read More